Tag: In the News,NSCLC,Non-Small Cell Lung Cancer,blood-based cancer test,cancer diagnostics,liquid biopsy,lung cancer,oncology,personalized medicine

  Personalized medicine promises to tailor treatments to patients’ diseases, so to determine whether a drug is suitable for a given patient, pharmaceutical companies are increasingly turning to companion diagnostic tests — tests that, by definition, are necessary to decide if a course of treatment is right for a particular patient. Many such companion tests…